Korro Bio has secured approvals in Australia to commence the Phase I/IIa trial of KRRO-110, aimed at treating AATD.

Rallybio has commenced an open-label Phase II trial of RLYB212 in pregnant women at higher risk for HPA-1a alloimmunisation ...

ImmunityBio has partnered with nCartes to automate and expedite the data fulfilment process for clinical trials.

A patient taking part in Neurogene’s Rett syndrome trial has died following complications from a rare hyperinflammatory syndrome. Credit: Shutterstock / romakhan3595. A patient taking part in ...

Neuralink has received approval from Health Canada to launch the first global trial, ‘Canadian Precise Robotically Implanted Brain-Computer Interface’ (CAN-PRIME), to evaluate its implantable device.

All patients had some form of vascular injury with no opportunity for revascularization, putting them at risk of infection or losing a limb. Credit: Shutterstock / Getmilitaryphotos Humacyte’s ...

In the rapidly evolving landscape of the clinical trials industry, the integration of robust marketing and sales intelligence solutions has become increasingly important. As stakeholders seek to ...

The company’s VP of digital excellence explains how the Japanese biotech engages with data and uses it to inform decision ...

Endeavor has dosed the first subject in the randomised Phase IIb WHISTLE-PF trial of ENV-101 (taladegib) for IPF.